121 related articles for article (PubMed ID: 6029163)
1. Progestin therapy of breast cancer: comparison of agents.
Stoll BA
Br Med J; 1967 Aug; 3(5561):338-41. PubMed ID: 6029163
[No Abstract] [Full Text] [Related]
2. Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer.
Iglódi F
Ther Hung; 1989; 37(4):205-8. PubMed ID: 2631288
[TBL] [Abstract][Full Text] [Related]
3. [Basis of gestagen therapy of endometrial carcinoma].
Trams G
Dtsch Med Wochenschr; 1978 Mar; 103(13):574-7. PubMed ID: 639688
[No Abstract] [Full Text] [Related]
4. [Hormone treatment of breast cancer in the advanced phase].
Demol R
Brux Med; 1968 Oct; 48(10):665-9. PubMed ID: 5757971
[No Abstract] [Full Text] [Related]
5. [Treatment of metastasizing breast cancer with anabolic steroids].
Hortling H; Malmio K
Nord Med; 1967 Mar; 77(9):275-9. PubMed ID: 6020758
[No Abstract] [Full Text] [Related]
6. [The limitations of therapy with progestational hormones].
Alicino R; Borsò N
Quad Clin Ostet Ginecol; 1967 Dec; 22(12):1045-54. PubMed ID: 5621697
[No Abstract] [Full Text] [Related]
7. Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.
Talley RW; O'Bryan RM; Burrows JH; San Diego EL
Cancer Chemother Rep; 1970 Aug; 54(4):249-53. PubMed ID: 4946009
[No Abstract] [Full Text] [Related]
8. Electrovaginal potentials, vaginal cytology, and hormone therapy.
Dederick MM; Hall TC; Yatsuhashi JW; Nevinny HB
Surg Gynecol Obstet; 1966 Oct; 123(4):751-4. PubMed ID: 5920369
[No Abstract] [Full Text] [Related]
9. The hormonal treatment of acroparaesthesia and night cramps.
Heber KR
Med J Aust; 1967 Jan; 1(4):154-7. PubMed ID: 4289519
[No Abstract] [Full Text] [Related]
10. A dose-response evaluation of androgens in the treatment of metastatic breast cancer.
Talley RW; Haines CR; Waters MN; Goldenberg IS; Olson KB; Bisel HF
Cancer; 1973 Aug; 32(2):315-20. PubMed ID: 4579091
[No Abstract] [Full Text] [Related]
11. [Vaginal smears in the management of adjuvant hormone therapy of breast cancer].
SICARD A; MARSAN C
Pathol Biol; 1959 Apr; 7(7-8):809-14. PubMed ID: 13667303
[No Abstract] [Full Text] [Related]
12. [Androgen therapy of incurable breast neoplasms. Controlled clinical study: nandrolone-testololactone-drostanolone].
Wolff G; Rieche K
Onkologie; 1978 Aug; 1(4):172-4. PubMed ID: 362297
[TBL] [Abstract][Full Text] [Related]
13. ANTITUMOR EFFICACY OF NORANDROLONE PHENPROPIONATE COMPARED WITH TESTOSTERONE PROPIONATE IN ADVANCED BREAST CANCER.
VOLK H; WILDE RC; CARABASI RA; BISEL HF
Cancer; 1965 May; 18():651-5. PubMed ID: 14278898
[No Abstract] [Full Text] [Related]
14. [Value of cyto-hormonal smears in the conduct of androgenic treatment of women with breast cancer].
Marsan C; Sicard A
Presse Med (1893); 1969 Dec; 77(54):2033-6. PubMed ID: 5378459
[No Abstract] [Full Text] [Related]
15. Therapeutic effect of a water-salt extract from BCG in two patients with advanced breast cancer.
Hadziev S; Kavaklieva-Dimtrova J; Mandulova P
Neoplasma; 1975; 22(3):269-72. PubMed ID: 1099468
[TBL] [Abstract][Full Text] [Related]
16. [Cytological check-up on the effectiveness of the hormonal treatment of endometriosis].
Kopecný J; Kopecná V
Cesk Gynekol; 1973; 38(1):38-9. PubMed ID: 4729366
[No Abstract] [Full Text] [Related]
17. A comparison of drostanolone propionate (Masteril) and nandrolone decanoate (Deca-durabolin) in the treatment of breast carcinoma.
Chowdhury MS; Banks AJ; Bond WH; Jones WG; Ward HW
Clin Oncol; 1976 Sep; 2(3):203-6. PubMed ID: 1036981
[No Abstract] [Full Text] [Related]
18. The effects of nandrolone, testosterone and their decanoate esters on murine lupus.
Verheul HA; Stimson WH; den Hollander FC; Schuurs AH
Clin Exp Immunol; 1981 Apr; 44(1):11-7. PubMed ID: 6973425
[TBL] [Abstract][Full Text] [Related]
19. [ACTION OF GESTAGENS ON ATROPHIC VAGINAL EPITHELIUM].
DELSOL JR; GARCIA-ORCOYEN J; DEALDAMA J
Tokoginecol Pract; 1964 Jul; 23():356-64. PubMed ID: 14272937
[No Abstract] [Full Text] [Related]
20. Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).
Banno K; Kisu I; Yanokura M; Tsuji K; Masuda K; Ueki A; Kobayashi Y; Yamagami W; Nomura H; Susumu N; Aoki D
Int J Oncol; 2012 Jun; 40(6):1755-62. PubMed ID: 22366992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
